WESTMINSTER, Colo.--(BUSINESS WIRE)--ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that it will make a presentation at the 27th Annual Piper Jaffray Healthcare Conference.
Date:
Tuesday, December 1, 2015
